Pharmacy

Accu Chek Multiclix

Home » Prescription Drugs 1 » Accu Chek Multiclix

Reduce the pain and hassle of testing. Unlike conventional lancing systems the ACCU-CHEK Multiclix lancet device is the only one with a six-lancet drum. It offers the least painful testing * with less hassle and improved safety. With 11 depth settings for maximum comfort and no side-to-side motion for less skin tearing.Self-contained six-lancet drums. No more lancets to see or handle. Just load the six-lancet drum and go.Personalized comfort. With 11 depth settings on the Comfort Dial you can adjust the lancet depth to match your skin type and obtain just enough blood for accurate testing.Precise lancing movement. A precise linear sliding motion reduces the lancet's side-to-side movement and tearing of your skin providing greater comfort.Precisely manufactured lancets. Careful manufacturing and grinding ensure that your lancets will not have bent or broken tips which can result in more painful testing.

Buy Accu Chek Multiclix and other Prescription Drugs 1 products online at Medstore.

Buy Online at Medstore - Click Here!

About Accu Chek Multiclix:

Product Type: Prescription Drugs 1

Accu-Chek Multiclix

Accu-Chek Multiclix

Accu-Chek Multiclix

Lancing Lancing 24 LNCTS Device + 12 LNCTS Accu-Chek Multiclix Accu-Chek Multiclix

View more Prescription Drugs 1

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.